Eco Animal Health Group (EAH LN)

Analysis

Health Care • United Kingdom

Eco Animal Health Group develops, registers, and markets pharmaceutical products for animals globally, specializing in veterinary pharmaceuticals, antibiotics, and vaccines for pigs and poultry. Its key product, Aivlosin®, is a macrolide antibiotic used to treat respiratory and enteric diseases in pigs and poultry. The company also offers generic drugs for parasitic and bacterial infections in various livestock. Headquartered in London, England, the company was founded in 1972.

Refresh

Exchange Announcement • 08 Oct 2026 23:32

Holding(s) in Company

Exchange Announcement • 17 Sep 2026 13:00

USDA-CVB approves ECOVAXXIN® MS field safety data

Exchange Announcement • 11 Sep 2026 15:11

Share Awards to Executive Directors

Exchange Announcement • 08 Sep 2026 23:35

Result of AGM

Exchange Announcement • 08 Sep 2026 13:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Holding(s) in Company

USDA-CVB approves ECOVAXXIN® MS field safety data

Share Awards to Executive Directors

Result of AGM

Didier Branellec appointed Non-Executive Director